SHIFT Newsroom · GLOBAL
Pancreatic cysts and GLP-1 use: a protocol for a safety study
A PLOS ONE protocol describes a retrospective study across three Swiss institutions examining GLP-1 exposure and progression of intraductal papillary mucinous neoplasms, a type of pancreatic cystic tumour.
A PLOS ONE protocol describes a retrospective study across three Swiss institutions examining GLP-1 exposure and progression of intraductal papillary mucinous neoplasms, a type of pancreatic cystic tumour. It concerns possible safety associations, not using GLP-1 medicines to treat these lesions. The protocol anticipates a small sample and cannot establish benefit, harm or causation before results are available.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.